http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2336849-T3
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2e4410855da087e11bf3eea8933fa |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-27 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-10 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4025 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4015 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12 |
filingDate | 2007-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2010-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f39c06e9b9cf326eb6777b656c54ecc9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_440c53ae6abb2daf7766eb17052eb8a6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4bdad27d9a6a23b520b501d04f1b00df http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14bee895e4b6e1106e38cfb00b7d7a60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18d203fe2bb646b590a80485fe98c012 |
publicationDate | 2010-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | ES-2336849-T3 |
titleOfInvention | INHIBITORS OF 11-BETA-HYDROXIESTEROID DEHYDROGENASE 1. |
abstract | A compound structurally represented by the formula: ** (See formula) ** in which R0 is ** (See formula) ** in which the dotted line represents the point of attachment to the position R0; in which Ra is -H or -halogen; Rb is -H or halogen; Rc is -H, -CH3 or -CH2-CH3; R1 is -H, -halogen, -O-CH3 (optionally substituted with one to three halogens) or -CH3 (optionally substituted with one to three halogens); R2 is -H, -halogen, -O-CH3 (optionally substituted with one to three halogens) or -CH3 (optionally substituted with one to three halogens); R3 is -H or -halogen; R4 is -OH, -halogen, -cyano, -alkyl (C1-C4) (optionally substituted with one to three halogens), -alkoxy (C1-C6) (optionally substituted with one to three halogens), -SCF3, -C (O) O (C1-C4) alkyl, -O-CH2-C (O) NH2, -C3-C8 cycloalkyl, -O-phenyl-C (O) O-(C1-C4) alkyl, -CH2- phenyl, -NHSO2-(C1-C4) alkyl, -NHSO2-phenyl (R21) (R21), -C1-C4 alkyl -C (O) N (R10) (R11), ** (See formula) * * in which the dotted line represents the point of attachment to position R4; R5 is -H, -halogen, -OH, -CN, -C1-C4 alkyl (optionally substituted with 1 to 3 halogens), -C (O) OH, -C (O) O-C1-C4 alkyl ), -C (O) -C1-C4 alkyl, -O-C1-C4 alkyl (optionally substituted with 1 to 3 halogens), -SO2-C1-C4 alkyl, -N (R8) ( R8), -phenyl (R21) (R21), -C (O) -NH-cycloalkyl (C3-C6), ** (See formula) ** in which the dotted line represents the point of attachment to the indicated position by R5; in which m is 1, 2 or 3; in which n is 0, 1 or 2, and in which when n is 0, then "(CH2) n" is a link; R6 is -H, -halogen, -CN or -C1-C4 alkyl (optionally substituted with 1 to 3 halogens); R7 is -H, -halogen or-(C1-C4) alkyl (optionally substituted with 1 to 3 halogens); R8 is independently each time -H or -C1-C6 alkyl (optionally substituted with 1 to 3 halogens) appears; R9 is -H or -halogen; R10 and R11 are each independently -H or -C1-C4 alkyl, or R11 and R12 taken together with the nitrogen to which they are attached form piperidinyl, piperazinyl or pyrrolidinyl; R20 is independently each time -H or -C1-C3 alkyl (optionally substituted with 1 to 3 halogens) appears; R21 is independently each time -H, -halogen or (C1-C3) alkyl (optionally substituted with 1 to 3 halogens) appears; R22 is independently each time -H or -C1-C6 alkyl (optionally substituted with 1 to 3 halogens) appears, and R23 is independently each time -H, -C1-C4 alkyl (optionally substituted with 1 up to 3 halogens) or -C (O) O-C1-C4 alkyl, or a pharmaceutically acceptable salt thereof. |
priorityDate | 2006-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 664.